These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Re-engineering drug discovery and development. FitzGerald GA LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582 [TBL] [Abstract][Full Text] [Related]
4. Leveraging public private partnerships to innovate under challenging budget times. Portilla LM; Rohrbaugh ML Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971 [TBL] [Abstract][Full Text] [Related]
5. An audience with...Francis Collins. Interviewed by Asher Mullard. Collins F Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031 [No Abstract] [Full Text] [Related]
6. The calculus of cures. Kocher R; Roberts B N Engl J Med; 2014 Apr; 370(16):1473-5. PubMed ID: 24571723 [No Abstract] [Full Text] [Related]
7. Drug development: Time for teamwork. May M Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427 [No Abstract] [Full Text] [Related]
8. Europe bets on drug discovery. Baker M Nature; 2013 Feb; 494(7435):20. PubMed ID: 23393658 [No Abstract] [Full Text] [Related]
9. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità . Ingrosso L; Rezza G; Pocchiari M; Garaci E Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551 [No Abstract] [Full Text] [Related]
10. Universities shun Europe's drug initiative. Gilbert N Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770 [No Abstract] [Full Text] [Related]
11. Making translation work. Williams RS; Desmond-Hellmann S Science; 2011 Jun; 332(6036):1359. PubMed ID: 21680815 [No Abstract] [Full Text] [Related]
12. The $2.6 billion pill--methodologic and policy considerations. Avorn J N Engl J Med; 2015 May; 372(20):1877-9. PubMed ID: 25970049 [No Abstract] [Full Text] [Related]
13. How can we improve the translational landscape for a faster cure of type 1 diabetes? von Herrath M; Chan A J Clin Invest; 2009 May; 119(5):1061-5. PubMed ID: 19422092 [TBL] [Abstract][Full Text] [Related]
14. The innovative medicines initiative: a case study for new ways of working in drug R&D. Laverty H; Goldman M Future Med Chem; 2014 Apr; 6(5):489-91. PubMed ID: 24649951 [No Abstract] [Full Text] [Related]
15. Is pharma running out of brainy ideas? Miller G Science; 2010 Jul; 329(5991):502-4. PubMed ID: 20671165 [No Abstract] [Full Text] [Related]
16. A three-step plan for antibiotics. Nature; 2014 May; 509(7502):533. PubMed ID: 24877183 [No Abstract] [Full Text] [Related]
17. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare. Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665 [TBL] [Abstract][Full Text] [Related]
18. Is the GAIN Act a turning point in new antibiotic discovery? Brown ED Can J Microbiol; 2013 Mar; 59(3):153-6. PubMed ID: 23540332 [TBL] [Abstract][Full Text] [Related]
19. Market watch: Upcoming catalysts in Q1 2015. Uribe A Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330 [No Abstract] [Full Text] [Related]
20. A cheat sheet to navigate the complex maze of exclusivities in the United States. Peng B; Tomas MC Pharm Pat Anal; 2014 Jul; 3(4):339-43. PubMed ID: 25291306 [No Abstract] [Full Text] [Related] [Next] [New Search]